|
Atomistry » Sodium » PDB 5hn3-5i9b » 5i8g | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Sodium » PDB 5hn3-5i9b » 5i8g » |
Sodium in PDB 5i8g: Cbp in Complex with CPD637 ((R)-4-Methyl-6-(1-Methyl-3-(1-Methyl-1H- Pyrazol-4-Yl)-1H-Indazol-5-Yl)-1,3,4,5-Tetrahydro-2H-Benzo[B][1, 4]Diazepin-2-One)Enzymatic activity of Cbp in Complex with CPD637 ((R)-4-Methyl-6-(1-Methyl-3-(1-Methyl-1H- Pyrazol-4-Yl)-1H-Indazol-5-Yl)-1,3,4,5-Tetrahydro-2H-Benzo[B][1, 4]Diazepin-2-One)
All present enzymatic activity of Cbp in Complex with CPD637 ((R)-4-Methyl-6-(1-Methyl-3-(1-Methyl-1H- Pyrazol-4-Yl)-1H-Indazol-5-Yl)-1,3,4,5-Tetrahydro-2H-Benzo[B][1, 4]Diazepin-2-One):
2.3.1.48; Protein crystallography data
The structure of Cbp in Complex with CPD637 ((R)-4-Methyl-6-(1-Methyl-3-(1-Methyl-1H- Pyrazol-4-Yl)-1H-Indazol-5-Yl)-1,3,4,5-Tetrahydro-2H-Benzo[B][1, 4]Diazepin-2-One), PDB code: 5i8g
was solved by
J.M.Murray,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 5i8g:
The structure of Cbp in Complex with CPD637 ((R)-4-Methyl-6-(1-Methyl-3-(1-Methyl-1H- Pyrazol-4-Yl)-1H-Indazol-5-Yl)-1,3,4,5-Tetrahydro-2H-Benzo[B][1, 4]Diazepin-2-One) also contains other interesting chemical elements:
Sodium Binding Sites:
The binding sites of Sodium atom in the Cbp in Complex with CPD637 ((R)-4-Methyl-6-(1-Methyl-3-(1-Methyl-1H- Pyrazol-4-Yl)-1H-Indazol-5-Yl)-1,3,4,5-Tetrahydro-2H-Benzo[B][1, 4]Diazepin-2-One)
(pdb code 5i8g). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Cbp in Complex with CPD637 ((R)-4-Methyl-6-(1-Methyl-3-(1-Methyl-1H- Pyrazol-4-Yl)-1H-Indazol-5-Yl)-1,3,4,5-Tetrahydro-2H-Benzo[B][1, 4]Diazepin-2-One), PDB code: 5i8g: Sodium binding site 1 out of 1 in 5i8gGo back to Sodium Binding Sites List in 5i8g
Sodium binding site 1 out
of 1 in the Cbp in Complex with CPD637 ((R)-4-Methyl-6-(1-Methyl-3-(1-Methyl-1H- Pyrazol-4-Yl)-1H-Indazol-5-Yl)-1,3,4,5-Tetrahydro-2H-Benzo[B][1, 4]Diazepin-2-One)
Mono view Stereo pair view
Reference:
A.M.Taylor,
A.Cote,
M.C.Hewitt,
R.Pastor,
Y.Leblanc,
C.G.Nasveschuk,
F.A.Romero,
T.D.Crawford,
N.Cantone,
H.Jayaram,
J.Setser,
J.Murray,
M.H.Beresini,
G.De Leon Boenig,
Z.Chen,
A.R.Conery,
R.T.Cummings,
L.A.Dakin,
E.M.Flynn,
O.W.Huang,
S.Kaufman,
P.J.Keller,
J.R.Kiefer,
T.Lai,
Y.Li,
J.Liao,
W.Liu,
H.Lu,
E.Pardo,
V.Tsui,
J.Wang,
Y.Wang,
Z.Xu,
F.Yan,
D.Yu,
L.Zawadzke,
X.Zhu,
X.Zhu,
R.J.Sims,
A.G.Cochran,
S.Bellon,
J.E.Audia,
S.Magnuson,
B.K.Albrecht.
Fragment-Based Discovery of A Selective and Cell-Active Benzodiazepinone Cbp/EP300 Bromodomain Inhibitor (Cpi-637). Acs Med.Chem.Lett. V. 7 531 2016.
Page generated: Mon Oct 7 21:33:16 2024
ISSN: ISSN 1948-5875 PubMed: 27190605 DOI: 10.1021/ACSMEDCHEMLETT.6B00075 |
Last articlesZn in 9JYWZn in 9IR4 Zn in 9IR3 Zn in 9GMX Zn in 9GMW Zn in 9JEJ Zn in 9ERF Zn in 9ERE Zn in 9EGV Zn in 9EGW |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |